Pharmacist-Intensivist Collaborative Telehealth for Post-Intensive Care Syndrome
Pharmacist-Intensivist Collaborative Telehealth for Post-Intensive Care Syndrome in Survivors of Critical Illness: a Pilot Randomized Controlled Trial
Malcom Randall VA Medical Center
24 participants
Jun 1, 2025
INTERVENTIONAL
Conditions
Summary
The goal of this pilot randomized controlled trial is to determine if a randomized controlled trial of a collaborative pharmacist-intensivist telehealth follow-up after intensive care unit discharge can feasibly be performed in patients who have survived a critical illness. The study intervention will be telehealth follow-up appointments provided by clinical pharmacists at approximately one and three months post-hospital discharge. The purpose of the follow-up appointments will be to assess for post-intensive care syndrome and provide recommend interventions aimed at improving recovery Participants will randomized to receive the study intervention or standard of care.
Eligibility
Inclusion Criteria5
- Adults 18-89 years of age
- Required admission to either medical or surgical ICU
- Respiratory failure requiring invasive mechanical ventilation of at least 24 hours during ICU stay; or ICU stay of at least 7 days
- Anticipated discharge to home after hospitalization
- Consent from patients themselves or a legally authorized representative if necessary
Exclusion Criteria5
- Pregnancy
- Incarceration/Imprisonment
- Life expectancy less than 6 months or enrolled in hospice/palliative care
- Anticipated discharge to skilled nursing facility, medical rehabilitation facility, or other long terms care facility
- Unable to participate in telehealth
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The post-ICU clinic follow-up will be conducted by a pharmacist via a telehealth visit. A collaborating physician (i.e. intensivist) will provide clinical support and oversight as needed. The appointments will be 30-60 minute telephone/video calls. Participants be assessed for PICS and recommended interventions to improve their care.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06983496